Notícias Aquestive Therapeutics Inc - AQST | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aquestive Therapeutics Inc (AQST)
Aquestive Therapeutics Inc (AQST) Notícias

Aquestive Therapeutics Inc (AQST)

3,01

-0,05

(-1,63%)

Fechado 21 Fevereiro 6:00PM

Atrasado por 15 minutos

3,04

0,03

( 1,00% )

Pré-mercado: 10:12AM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

2
3
4
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Aquestive Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições